Novartis Plays Down Impact Of Split High Court Ruling
Defending its calls for summary judgment against plaintiffs in multidistrict litigation over its controversial bone cancer drugs, Novartis Pharmaceuticals Corp. has contended that a recent high court decision has no bearing...To view the full article, register now.
Already a subscriber? Click here to view full article